These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
150 related items for PubMed ID: 6884702
1. Intracellular distribution of N4-behenoyl-1-beta-D-arabinofuranosylcytosine in blood cells. Ueda T, Nakamura T, Kagawa D, Yamamoto K, Uchida M, Sasada M, Uchino H. Gan; 1983 Jun; 74(3):445-51. PubMed ID: 6884702 [Abstract] [Full Text] [Related]
2. Production of N4-succinyl-1-beta-D-arabinofuranosylcytosine, a novel metabolite of N4-behenoyl-1-beta-D-arabinofuranosylcytosine, in mice and its biological significance. Oh-ishi J, Kataoka T, Tsukagoshi S, Sakurai Y, Shibukawa M, Kobayashi H. Cancer Res; 1981 Jun; 41(6):2501-6. PubMed ID: 7237444 [Abstract] [Full Text] [Related]
3. Effect and mode of action of N4-behenoyl-beta-D-arabinofuranosylcytosine. Kataoka T, Sakurai Y. Recent Results Cancer Res; 1980 Jun; 70():147-51. PubMed ID: 7355245 [Abstract] [Full Text] [Related]
4. Incorporation of N4-behenoyl-1-beta-D-arabinofuranosylcytosine into DNA as 1-beta-D-arabinofuranosylcytosine. Higashigawa M, Ochiai H, Ohkubo T, Kawasaki H, Nobori T, Kamiya H, Sakurai M. Med Oncol Tumor Pharmacother; 1988 Jun; 5(4):265-71. PubMed ID: 2848163 [Abstract] [Full Text] [Related]
5. Cytotoxicity of N4-behenoyl-1-beta-D-arabinofuranosylcytosine through gradual conversion to 1-beta-D-arabinofuranosylcytosine in HeLa cells. Maehara Y, Kusumoto T, Sakaguchi Y, Kusumoto H, Anai H, Sugimachi K. Anticancer Res; 1989 Jun; 9(1):41-4. PubMed ID: 2705754 [Abstract] [Full Text] [Related]
6. In vivo distribution of 14C-labeled N4-behenoyl-1-beta-D-arabinofuranosylcytosine in mice. Toyoshima S, Fukuma M, Seto Y, Fujita H, Fukushima K, Tomioka H, Sakurai T, Sugimoto Y, Yagi T, Hoshino T, Sowa T. Gan; 1981 Feb; 72(1):19-29. PubMed ID: 7274645 [Abstract] [Full Text] [Related]
7. Pharmacokinetics of N4-behenoyl-1-beta-D-arabinofuranosylcytosine in patients with acute leukemia. Ueda T, Nakamura T, Ando S, Kagawa D, Sasada M, Uchino H, Johno I, Akiyama Y. Cancer Res; 1983 Jul; 43(7):3412-6. PubMed ID: 6850647 [Abstract] [Full Text] [Related]
8. [Experimental study on the correlation between the antitumor activity and pharmacokinetics of cytosine arabinoside (Ara-C) and N4-behenoyl-1-beta-D-arabinofuranosylcytosine (BH-AC)]. Takenaka T, Kimura K. Nihon Gan Chiryo Gakkai Shi; 1985 Dec 20; 20(10):2322-8. PubMed ID: 3831176 [No Abstract] [Full Text] [Related]
9. N4-Behenoyl-1-beta-D-arabinofuranosylcytosine as a potential new antitumor agent. Aoshima M, Tsukagoshi S, Sakurai Y, Oh-ishi JI, Ishida T. Cancer Res; 1977 Aug 20; 37(8 Pt 1):2481-6. PubMed ID: 872077 [Abstract] [Full Text] [Related]
10. Antitumor effects and pharmacology of orally administered N4-palmitoyl-1-beta-D-arabinofuranosylcytosine in mice. Hori K, Tsuruo T, Naganuma K, Tsukagoshi S, Sakurai Y. Cancer Res; 1984 Jan 20; 44(1):172-7. PubMed ID: 6690034 [Abstract] [Full Text] [Related]
11. Membrane affinity and metabolism of N4-palmitoyl-1-beta-D-arabinofuranosylcytosine into cultured KB cells. Tsuruo T, Iida H, Hori K, Tsukagoshi S, Sakurai Y. Cancer Res; 1981 Nov 20; 41(11 Pt 1):4484-8. PubMed ID: 7306971 [Abstract] [Full Text] [Related]
12. [The simultaneous determination of Ara-U and Ara-C, urinary metabolites of N4-behenoyl-1-beta-D-arabinofuranosylcytosine by mass fragmentography (author's transl)]. Makino Y, Matsubara Y, Watanabe K, Hirobe M. Yakugaku Zasshi; 1982 Jan 20; 102(1):49-55. PubMed ID: 7086638 [No Abstract] [Full Text] [Related]
13. Metabolism of the new liposomal anticancer drug N4-octadecyl-1-beta-D-arabinofuranosylcytosine in mice. Koller-Lucae SK, Suter MJ, Rentsch KM, Schott H, Schwendener RA. Drug Metab Dispos; 1999 Mar 20; 27(3):342-50. PubMed ID: 10064564 [Abstract] [Full Text] [Related]
14. Formulation, stability, and antitumor activity of 1-beta-D-arabinofuranosylcytosine conjugate of thioether phospholipid. Hong CI, Bernacki RJ, Hui SW, Rustum Y, West CR. Cancer Res; 1990 Jul 15; 50(14):4401-6. PubMed ID: 2364392 [Abstract] [Full Text] [Related]
15. Metabolism and selective effects of 1-beta-D-arabinofuranosylcytosine in L1210 and Host tissues in vivo. Chou TC, Hutchinson DJ, Schmid FA, Philips FS. Cancer Res; 1975 Jan 15; 35(1):225-36. PubMed ID: 1109791 [Abstract] [Full Text] [Related]
16. Formation of 1-beta-D-arabinofuranosylcytosine diphosphate choline in neoplastic and normal cells. Lauzon GJ, Paterson AR, Belch AW. Cancer Res; 1978 Jun 15; 38(6):1730-3. PubMed ID: 274175 [Abstract] [Full Text] [Related]
17. Lipophilic 5'-(alkyl phosphate) esters of 1-beta-D-arabinofuranosylcytosine and its N4-acyl and 2,2'-anhydro-3'-O-acyl derivatives as potential prodrugs. Rosowsky A, Kim SH, Ross J, Wick MM. J Med Chem; 1982 Feb 15; 25(2):171-8. PubMed ID: 7057424 [Abstract] [Full Text] [Related]
18. Enzyme catalyzation of the deacylation of N4-acyl derivatives of 1-beta-D-arabinofuranosylcytosine in the mouse liver microsome. Tsuruo T, Hori K, Iida H, Tsukagoshi S, Sakurai Y. Cancer Res; 1982 Jun 15; 42(6):2250-4. PubMed ID: 7074607 [Abstract] [Full Text] [Related]
19. In vitro sensitivity of various human tumors to 1-beta-D-arabinofuranosylcytosine and N4-behenoyl-1-beta-D-arabinofuranosylcytosine. Maehara Y, Kusumoto T, Kusumoto H, Anai H, Sugimachi K. Chemotherapy; 1989 Jun 15; 35(3):181-6. PubMed ID: 2766858 [Abstract] [Full Text] [Related]
20. Plasma and leukemic cell pharmacokinetics of high-dose N4-behenoyl-1-beta-D-arabinofuranosylcytosine in acute leukemia patients. Yoshida T, Kobayashi K, Okabe Y, Okumura H, Matano S, Kanno M, Takeda Y, Ohtake S, Nakamura S, Matuda T. J Clin Pharmacol; 1994 Jan 15; 34(1):52-9. PubMed ID: 8132852 [Abstract] [Full Text] [Related] Page: [Next] [New Search]